The responsible technician (RT) requirement in Brazil
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Brazil requires regulated companies to appoint a statutory technical responsible person (RT), and the device label must state that person’s name — RDC 751/2022, Article 47, and Decreto 8.077/2013, Article 5, together pin this duty onto a specific individual. Without an RT, neither the operating authorization nor the product registration can proceed, and this is a point first-time entrants most often discover too late. GRZAN flags it at the very start of every Brazilian engagement, because recruiting the right person has its own timeline that cannot be compressed at the end.
2. Legal basis
- Operating conditions for companies subject to health licensing — Decreto No. 8.077/2013, published on August 14, 2013; Article 5 (statutory technical responsible person), Article 3 (licensing prerequisites: technical capacity, qualified personnel), Article 2, and Article 24 (legal entities, natural persons, and the technical responsible person and legal representative personally bear civil and administrative liability under Lei No. 6.437/1977)
- Classification, Notification and Registration of Medical Devices and the Requirements for Labels and Instructions for Use — RDC No. 751/2022, resolution of September 15, 2022, in force as of March 1, 2023; Article 46, item I, and Article 47
- Essential Safety and Performance Requirements — RDC No. 848/2024, in force 180 days from the date of publication (Article 88), with the effectiveness notice issued by ANVISA on September 10, 2024; Article 85
- Law on Health Surveillance of Medicines, Active Ingredients and Related Products — Lei No. 6.360/1976, published on September 23, 1976; Article 8 (statutory technical responsible person) [practical estimate, subject to what ANVISA publishes]
3. Expert insights
The GRZAN view: in Brazil the RT is not a relabeled quality manager but a statutory post attached to the company’s licensing. Decreto 8.077/2013, Article 3, lists qualified personnel among the prerequisites for licensing, and Article 5 requires the appointment of a statutory technical responsible person; both run in parallel with product registration. An operating authorization without an RT is not valid, and a product that holds a certificate while the company has no RT is equally in trouble, so the two tracks must be closed together.
The second point comes from the knock-on effect of the label signature. Article 47 requires the label to state the technical responsible person’s name, which means the RT’s name travels with the product into hospitals and to the end user. Once a vigilance event or a field action occurs, the RT is the direct point of contact at the regulatory and judicial level. GRZAN recommends explaining this layer of responsibility before the appointment is accepted, so the candidate does not withdraw at the last moment and delay the entire filing.
Third, the boundaries of responsibility need written support. The scope of what the RT signs, the situations in which the RT may refuse to sign, and the handover procedure on departure should all be stated in the appointment documents and the quality system documentation. Without written boundaries, whenever a quality dispute arises inside the company, the RT tends to become the single landing point for responsibility, whatever the actual facts.
The fourth point concerns personnel stability. A change of RT triggers synchronized updates across labels, instructions for use and registration information. Companies that rotate RTs frequently face rising relabel costs and compliance risk, and this is especially visible in Brazilian entities operating at small scale, where every update consumes proportionally more of the compliance budget.
The fifth point is the hardest one in this article, and the most often missed: Decreto 8.077/2013, Article 24, provides that legal entities, natural persons, and the technical responsible person and the legal representative personally bear civil and administrative liability, dealt with under Lei 6.437/1977. This is much harder than the frequently cited duty to have an RT under Article 5: Article 5 is about establishing the post, Article 24 is about personal liability. GRZAN puts the text of Article 24 on the table during appointment negotiations, so the candidate has an accurate expectation of every signature they will give.
The sixth point connects two instruments of different hierarchy to the same penalty law: RDC 848/2024, Article 85, provides that violating the essential safety and performance requirements constitutes a health infraction, likewise dealt with under Lei 6.437/1977. A single signature by an RT may therefore trigger two chains at once — the company level through RDC 848/2024, Article 85, and the personal level through Decreto 8.077/2013, Article 24 — and both chains end at the same penalty law. GRZAN’s conclusion: the RT’s responsibility is not a single-provision post duty but a two-layer stack.
The seventh point concerns recruitment difficulty. A qualified RT needs a locally recognized professional qualification and a willingness to carry a named signature responsibility, and such people are not abundant in the market. GRZAN recommends running the RT search as an independent workstream parallel to the registration, not as a favor to be handled incidentally by the Brazilian partner, because it is exactly the kind of task that surfaces as a blocker on the eve of submission.
4. Practical recommendations
Start RT recruitment at the stage of setting up the Brazilian entity, not in the weeks before the registration filing. After the appointment, maintain two registers: one listing the technical documents the RT has signed, and one recording handover on departure, both with signatures and dates. The registers should also track the validity of the RT’s qualification certificate, starting the renewal early enough that an expired credential never undermines the force of a signature.
Before the label is finalized, verify that the RT’s name and the registration number match the ANVISA records; when the RT changes, the labels, instructions for use and registration information must be updated in step, not merely the internal documents. The scope of synchronized updates also includes label stock already printed but unused, which should be handled under the applicable stock-consumption rules for changes where necessary.
In addition, prepare a backup candidate for the RT post who also meets the professional qualification requirements, and pre-assemble the appointment documents so that a replacement can take effect immediately when a vacancy appears. During a vacancy, several compliance actions of the company may have to pause, including signatures on amendment applications and vigilance responses, a risk that rarely appears in budgets or schedules yet is entirely predictable.
5. Verification checklist
- □ Has the Brazilian entity appointed a statutory technical responsible person with appointment documents retained
- □ Does the RT’s qualification meet the local professional council requirements
- □ Does the label state the RT’s name (Article 47)
- □ Are the RT’s signing scope and departure handover procedure written into the system documentation
- □ Are labels, instructions for use and registration information updated in step when the RT changes
- □ Have the RT and the legal representative given written confirmation of personal liability under Decreto 8.077/2013, Article 24
- □ Are the company-level chain under RDC 848/2024, Article 85, and the personal-level chain under Article 24 covered in internal training
Regulatory information verified as of October 29, 2026
GRZAN Regulatory Team
GRZAN supports manufacturers entering the Brazilian market across the full holder and import chain: holder-structure design, AFE and operating authorization planning, importer qualification, vigilance readiness and official fee budgeting. For tailored support on Brazilian license holders, import qualifications and fee budgets, contact info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us